Infraglottic Devices Segment to Account for Largest Share in Airway Management Devices Market During 2022-2028

According to our latest study on "Airway Management Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product and End User," the market is expected to grow from US$ 1,944.88 million in 2021 to US$ 3,100.64 million by 2028; it is expected to grow at a CAGR of 6.9% from 2022 to 2028. The report highlights the key factors driving the market and prominent players with their developments in the market.

The increasing prevalence of various chronic disorders, such as asthma, COPD, cystic fibrosis, and emphysema, among a large population globally has fueled new product developments, product launches, and approvals on a global level. Additionally, major market players are involved in research and development activities to ensure the innovation and development of efficient products. For instance, in July 2022, Verathon announced the release of the BFlex 2.8 Single-use Bronchoscope. BFlex single-use bronchoscopes are designed specifically for the critical needs of the ICU, OR, and ED. The BFlex 2.8 is Verathon's first single-use pediatric bronchoscope and delivers the drivability and image quality needed for pediatric bronchoscopies, airway management, and lung isolation procedures. In May 2021, Olympus Corporation received FDA 510(k) clearance for its Airway Mobilescopes-MAF-TM2, MAF-GM2, and MAF-DM2-enabling providers to perform a variety of upper and lower airway management procedures. Thus, an increase in product development, launches, and approvals is driving the airway management devices market.

The COVID-19 pandemic fueled the demand for respiratory medical devices such as airway management devices. Various companies took the initiative to bring new and advanced airway management devices during the pandemic in 2020. For instance, in October 2021, to mitigate the risks of infection, particularly during tracheal intubation, ventilator disconnections, and extubation, the need to create a specific device for clamping the ETT during the pandemic was identified and Indumel, a company based in Portugal, a device with characteristics that could overcome previously described difficulties was developed. In addition, in April 2020, EOlife was developed by Archeon to monitor the mechanical ventilation of COVID-19 patients in France. EOlife monitored the ventilatory parameters of each patient by connecting a single-use sensor to different ventilators and adjusting the amount of air supplied according to the results transmitted by the software. The resuscitation services were able to ventilate more patients with better efficiency temporarily. Moreover, as the number of people infected with airway obstruction steeply increased, the demand for airway management devices proliferated. Thus, the overall COVID-19 impact on the airway management devices market was positive.

Based on product, the global airway management devices market is segmented into infraglottic devices, supraglottic devices, laryngoscopes, resuscitators, and others. The infraglottic devices segment held the largest share of the market in 2021; however, the supraglottic devices segment is anticipated to register the highest CAGR of 7.2% during the forecast period. Based on end user, the global airway management devices market is segmented into hospitals, ambulatory surgical care centers, and others. The hospital segment accounted for the largest share of the airway management devices market in 2021.

Teleflex Incorporated; Smiths Medical; Medtronic; Intersurgical Ltd; Ambu A/S; Medline Industries, Inc.; Koninklijke Philips N.V.; Armstrong Medical; Mercury Medical; and Cook Medical LLC are among the leading companies operating in the airway management devices market.

Based on geography, the global airway management devices market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa (MEA), and South & Central America. The airway management devices market in North America is further segmented into the US, Canada, and Mexico. The European airway management devices market is subsegmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The airway management devices market in Asia Pacific is subsegmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The airway management devices market in the MEA is further segmented into South Africa, Saudi Arabia, the UAE, and the Rest of the MEA. The airway management devices market in South & Central America is subsegmented into Brazil, Argentina, and the Rest of South & Central America.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com